2022
DOI: 10.1016/j.omto.2022.04.009
|View full text |Cite
|
Sign up to set email alerts
|

Modulation of p53 expression in cancer-associated fibroblasts prevents peritoneal metastasis of gastric cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
9
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 11 publications
(14 citation statements)
references
References 49 publications
1
9
0
Order By: Relevance
“…The present study reveals a strong relationship between CAFs and survival. Patients with high α-SMA and FAP expression had significantly worse RFS and DSS ( Figure 4 ), in line with previous reports in gastrointestinal surgical oncology ( 14 , 15 ). Moreover, our multivariable analyses suggested that α-SMA was an independent predictor of RFS and DSS after surgery ( Tables 3 , 4 ).…”
Section: Discussionsupporting
confidence: 91%
See 2 more Smart Citations
“…The present study reveals a strong relationship between CAFs and survival. Patients with high α-SMA and FAP expression had significantly worse RFS and DSS ( Figure 4 ), in line with previous reports in gastrointestinal surgical oncology ( 14 , 15 ). Moreover, our multivariable analyses suggested that α-SMA was an independent predictor of RFS and DSS after surgery ( Tables 3 , 4 ).…”
Section: Discussionsupporting
confidence: 91%
“…A recent review reported the association of CAFs with cancer invasion and metastasis that occurs through extracellular matrix deposition and remodeling, epithelial-mesenchymal transition in cancer cells, and secretion of growth factors supporting cancer cells ( 17 ). Furthermore, potential CAF-targeted therapeutic strategies have been suggested ( 6 , 14 17 ). There are ongoing clinical trials investigating the efficacy of CAF-targeted therapies combined with existing therapies ( 8 , 18 20 ).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…As noted earlier, cancer cells induce transcriptional alterations of p53 in CAFs relative to normal NFs [ 235 , 237 ], including in gastric cancer [ 547 ]. Gene therapy with a replicative oncolytic adenovirus-expressing wild-type p53 gene (OBP-702) against CAFs and peritoneal metastases in gastric cancer (GC) resulted in cytotoxicity to both gastric cancer cells and CAFs but not to normal gastric fibroblasts in a murine model [ 547 ].…”
Section: Cancer Stroma As a Therapeutic Targetmentioning
confidence: 97%
“…Gene therapy with a replicative oncolytic adenovirus-expressing wild-type p53 gene (OBP-702) against CAFs and peritoneal metastases in gastric cancer (GC) resulted in cytotoxicity to both gastric cancer cells and CAFs but not to normal gastric fibroblasts in a murine model [ 547 ]. It induced apoptosis and autophagy in CAFs, decreased their secretion of cancer-promoting cytokines, was synergistic with paclitaxel in inhibiting the growth of peritoneal metastases, and decreased CAFs in peritoneal metastases [ 547 ].…”
Section: Cancer Stroma As a Therapeutic Targetmentioning
confidence: 99%